ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
-0,01%
Bitcoin
67.722,82
0,36%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Biodesix Inc (BDSX)

  7. Biodesix Inc (BDSX) News

BDSX

Biodesix (BDSX)

Biodesix Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BDSX
DatumZeitQuelleÜberschriftSymbolFirma
28/05/202412h00Business WireBiodesix to Participate in Two Investor Conferences in JuneNASDAQ:BDSXBiodesix Inc
24/05/202422h11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BDSXBiodesix Inc
24/05/202401h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
24/05/202401h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
24/05/202401h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
24/05/202401h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
24/05/202401h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
24/05/202401h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
24/05/202401h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
24/05/202401h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
24/05/202401h09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BDSXBiodesix Inc
21/05/202412h00Business WireBiodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
10/05/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202423h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202423h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202423h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202422h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202422h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202422h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202422h04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
08/05/202422h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDSXBiodesix Inc
08/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDSXBiodesix Inc
08/05/202422h01Business WireBiodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule ManagementNASDAQ:BDSXBiodesix Inc
07/05/202412h00Business WireBiodesix to Participate in the 2024 RBCCM Global Healthcare ConferenceNASDAQ:BDSXBiodesix Inc
24/04/202412h00Business WireBiodesix to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:BDSXBiodesix Inc
09/04/202423h00Business WireBiodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
05/04/202413h17Business WireBiodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private PlacementNASDAQ:BDSXBiodesix Inc
25/03/202411h00Business WireBiodesix Announces New Master Collaborative Research Agreement with Leading US Cancer CenterNASDAQ:BDSXBiodesix Inc
01/03/202412h11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BDSXBiodesix Inc
 Showing the most relevant articles for your search:NASDAQ:BDSX

Kürzlich von Ihnen besucht

TG
RHM
Rheinmetall
TG
D7G
Nel ASA
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
TSLA
Tesla
TG
BAYN
Bayer
CCOM
US100
US Tech 100
NYSE
MRK
Merck
FX
EURJPY
Euro vs Yen
TG
432
Arbor Metals
TG
DBK
Deutsche Bank
DBI
DAX
DAX
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten